Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
Sekeres
Mikkael A
MA
Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA. sekerem@ccf.org
Kantarjian
Hagop
H
Fenaux
Pierre
P
Becker
Pamela
P
Boruchov
Adam
A
Guerci-Bresler
Agnes
A
Hu
Kuolung
K
Franklin
Janet
J
Wang
Yow-Ming C
YM
Berger
Dietmar
D